Interpreting Skin Material in Morgellons Research: A Focused Critical Comparison

Magnifying glass over research papers beside glass slides and a laboratory microscope.

Jeremy Murphree MorgellonsSurvey.org October 18, 2026

Not peer reviewed. Independent source and specialist verification remain pending.

Abstract

Descriptions of skin-associated material can refer to its appearance, location, composition, proposed origin, or clinical significance. These questions require different evidence. This focused comparison examines two specimen investigations relevant to Morgellons, a subsequent narrative review, and a separate hair-cast case report, with two companion reports used to trace collection methods and cohort relationships. It considers specimen denominators, the interpretation of protein findings, explicitly reported patient overlap, citation placement, and terminology. The comparison identifies places where a concise description can obscure the limits of the underlying observation. Environmental material should be distinguished from material interpreted as shed skin and from collection or processing artifact; protein detection should be distinguished from identification of a particular filament; and publication of a description should be distinguished from a separately documented specimen investigation. A proposed reporting record would connect each claim to a defined structure, specimen context, analytical method, and stated uncertainty. This comparison does not establish a disease mechanism, diagnostic criterion, or treatment recommendation.

Keywords: Morgellons; skin material; dermal filaments; follicular casts; specimen provenance; histopathology; critical comparison

Read more

The Closed Loop: When Lyme Advocacy Stops Questioning Itself

Lyme disease echo chamber showing doctors, advocates, podcasts, websites and patient groups circulating information inside a closed loop

The Lyme disease community was built, in large part, by people willing to question authority. That history makes the possibility of a Lyme disease echo chamber particularly uncomfortable to discuss. Patients challenged physicians who dismissed symptoms that did not fit established diagnostic categories. Advocates questioned testing standards they believed were inadequate, while researchers pushed against assumptions about diagnosis, treatment, persistence, and coinfections. That willingness to challenge prevailing ideas has often been one of the community’s greatest strengths. It forced difficult conversations and created space for patients who felt abandoned by conventional medicine.

But skepticism only has value when we apply it consistently. A community that demands scrutiny of government agencies, professional societies, insurance companies, and academic medicine should also scrutinize its own physicians, researchers, laboratories, advocacy organizations, websites, podcasts, and influential personalities. We cannot insist that outside institutions tolerate uncomfortable questions while treating the same questions differently when they point inward. Skepticism stops functioning as a method when it depends on who receives it.

Read more